You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Giant cell

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

Recruiting
  • Rheumatoid Arthritis
  • +3 more
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Apr 25, 2022

    Advanced Malignant Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath Trial in Worldwide (DCC-3014)

    Recruiting
    • Advanced Malignant Neoplasm
    • +4 more
    • Palo Alto, California
    • +23 more
    Dec 21, 2021

    Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Giant Cell Glioblastoma
    • +2 more
    • Laboratory Biomarker Analysis
    • Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Jan 4, 2023

    Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

    Active, not recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • Radiation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Horton Disease Trial in Dijon (blood samples)

    Recruiting
    • Horton Disease
    • blood samples
    • Dijon, France
      CHU Dijon Bourgogne
    Sep 28, 2021

    22Mhz and 18Mhz High-frequency Probes for Ultrasound Study of

    Completed
    • Giant Cell Arteritis
      • Brest, France
        CHRU de Brest
      Aug 23, 2021

      Giant Cell Arteritis Trial in Worldwide (Guselkumab, Placebo)

      Recruiting
      • Giant Cell Arteritis
      • Kansas City, Kansas
      • +33 more
      Aug 11, 2022

      Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

      Recruiting
      • Astrocytoma, Grades II, III and IV
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 31, 2023

      Giant Cell Tumor of Bone Trial in Worldwide (Denosumab (Cohort A))

      Active, not recruiting
      • Giant Cell Tumor of Bone
      • Denosumab (Cohort A)
      • Santa Monica, California
      • +13 more
      Dec 21, 2021

      Giant Cell Arteritis Trial in Bern (Tocilizumab, Glucocorticoids)

      Completed
      • Giant Cell Arteritis
      • Bern, Switzerland
        University Hospital Bern, Inselspital
      Jun 21, 2021

      Rheumatoid Arthritis, Giant Cell Arteritis Trial in Australia, India, New Zealand (Tocilizumab Prefilled Syringe)

      Active, not recruiting
      • Rheumatoid Arthritis
      • Giant Cell Arteritis
      • Tocilizumab Prefilled Syringe
      • Brisbane, Australia
      • +3 more
      May 4, 2022

      Patient-reported Outcomes in Polymyalgia Rheumatica

      Recruiting
      • Polymyalgia Rheumatica
        • Leuven, Belgium
          University Hospitals Leuven
        Sep 13, 2022

        Polymyalgia Rheumatica, Effect of Drug, Safety Issues Trial in Shanghai (Tofacitinib 5 MG)

        Completed
        • Polymyalgia Rheumatica
        • +2 more
        • Tofacitinib 5 MG
        • Shanghai, China
          Ren Ji Hospital
        Sep 12, 2022

        Giant Cell Tumor of the Bone in Young Patients

        Completed
        • Giant Cell Tumor of Bone
          • Bologna, Italy
            Istituto Ortopedico Rizzoli
          May 3, 2021

          Giant Cell Arteritis, Optic Ischaemic Neuropathy Trial in France (tocilizumab and IV steroids combination, IV steroids

          Recruiting
          • Giant Cell Arteritis
          • Optic Ischaemic Neuropathy
          • tocilizumab and IV steroids combination
          • IV steroids combination alone
          • Caen, France
          • +9 more
          Mar 3, 2022

          Polymyalgia Rheumatica Trial (Secukinumab 300 mg, Secukinumab 150 mg, Placebo to secukinumab)

          Not yet recruiting
          • Polymyalgia Rheumatica
          • Secukinumab 300 mg
          • +2 more
          • (no location specified)
          Mar 6, 2023

          Improved Diagnostics and Monitoring of Polymyalgia Rheumatica

          Recruiting
          • Polymyalgia Rheumatica
          • +2 more
          • PET/CT
          • Aarhus, Denmark
          • +2 more
          Dec 10, 2021

          Patients Treated for Giant Cells ARTEitis (Horton's Disease)

          Recruiting
          • Giant Cell Arteritis
          • Horton Disease
          • no intervention
          • Nîmes, France
            CHUNimes
          Jul 27, 2021

          PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS

          Recruiting
          • Inflammatory Rheumatism
          • +5 more
            • Angers, France
            • +9 more
            May 4, 2022

            Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

            Recruiting
            • Bone Sarcoma
            • +15 more
            • Aldesleukin
            • +8 more
            • Houston, Texas
              M D Anderson Cancer Center
            Aug 3, 2022

            Prognostic Prediction Based on Radiomics of Giant Cell Tumor of

            Completed
            • Spinal Tumor
            • RANK/RANKL(RANK: Receptor Activator of Nuclear factor Kappa-Β /RANKL:Receptor Activator of Nuclear factor Kappa-Β Ligand)
            • Beijing, Please Select An Option Below, China
              Peking University third hospital
            Jun 28, 2021

            Giant Cell Arteritis Trial in Boston (Tocilizumab, Prednisone)

            Recruiting
            • Giant Cell Arteritis
            • Boston, Massachusetts
              Massachusetts General Hospital
            Jul 23, 2021

            Giant Cell Arteritis, Neurovascular Disorder Trial in Paris (Tocilizumab, Placebo)

            Not yet recruiting
            • Giant Cell Arteritis
            • Neurovascular Disorder
            • Paris, France
              Saint Antoine Hospital, Neurology Unit, Assistance Publique-Hôpi
            May 14, 2021

            Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor Trial in Worldwide (FPA008)

            Completed
            Has Results
            • Pigmented Villonodular Synovitis
            • Tenosynovial Giant Cell Tumor
            • FPA008
            • Los Angeles, California
            • +11 more
            Aug 4, 2021

            Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome

            Recruiting
            • Polymyalgia Rheumatica
            • Sjogren's Syndrome
              • Brest, France
                CHRU Brest
              Mar 28, 2022